Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:50 AM UTC
| NCT Number | NCT06797635 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 372 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 19, 2026: Clinical trial NCT06797635 is currently recruiting participants. This phase2 study for breast cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06797635 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06797635 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.